Sapiens International - SPNS Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $41.67
  • Forecasted Upside: 5.62%
  • Number of Analysts: 3
  • Breakdown:
  • 1 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$39.45
▼ -0.03 (-0.08%)

This chart shows the closing price for SPNS by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Sapiens International Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SPNS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SPNS

Analyst Price Target is $41.67
▲ +5.62% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Sapiens International in the last 3 months. The average price target is $41.67, with a high forecast of $44.00 and a low forecast of $38.00. The average price target represents a 5.62% upside from the last price of $39.45.

This chart shows the closing price for SPNS for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 3 investment analysts is to hold stock in Sapiens International. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 2 sell ratings
5/20/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 2 sell ratings
8/18/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 2 sell ratings
11/16/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 1 sell ratings
2/14/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 1 sell ratings
5/14/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 1 sell ratings
8/12/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 1 sell ratings
10/11/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 1 sell ratings
11/10/2024

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/2/2024The Goldman Sachs GroupBoost TargetBuy ➝ Buy$38.00 ➝ $43.00
8/2/2024BarclaysBoost TargetUnderweight ➝ Underweight$30.00 ➝ $38.00
8/2/2024Needham & Company LLCBoost TargetBuy ➝ Buy$38.00 ➝ $44.00
5/8/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$38.00
2/21/2024The Goldman Sachs GroupBoost TargetBuy ➝ Buy$34.00 ➝ $38.00
2/21/2024BarclaysBoost TargetUnderweight ➝ Underweight$28.00 ➝ $30.00
8/3/2023The Goldman Sachs GroupBoost TargetBuy ➝ Buy$28.00 ➝ $34.00
8/3/2023BarclaysBoost TargetUnderweight ➝ Underweight$24.00 ➝ $28.00
8/2/2023Needham & Company LLCBoost TargetBuy ➝ Buy$26.00 ➝ $35.00
5/5/2023BarclaysDowngradeEqual Weight ➝ Underweight$24.00
2/22/2023Needham & Company LLCBoost TargetBuy$22.00 ➝ $24.00
2/22/2023BarclaysBoost TargetEqual Weight$22.00 ➝ $24.00
2/21/2023The Goldman Sachs GroupLower TargetBuy$28.00 ➝ $26.00
1/23/2023The Goldman Sachs GroupInitiated CoverageBuy$28.00
12/1/2022JPMorgan Chase & Co.Initiated CoverageUnderweight$20.00
11/4/2022Needham & Company LLCLower TargetBuy$30.00 ➝ $22.00
8/8/2022CitigroupLower TargetBuy$27.00 ➝ $25.00
8/4/2022Needham & Company LLCLower TargetBuy$32.00 ➝ $30.00
5/3/2022William BlairReiterated RatingMarket Perform
2/24/2022CitigroupLower TargetBuy$38.00 ➝ $30.00
2/24/2022Needham & Company LLCLower TargetBuy$40.00 ➝ $36.00
12/14/2021JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$35.00
11/4/2021CitigroupBoost TargetBuy$36.00 ➝ $38.00
7/13/2021JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$35.00
6/3/2021The Goldman Sachs GroupDowngradeNeutral ➝ Sell$34.00 ➝ $27.00
1/20/2021Jefferies Financial GroupInitiated CoverageBuy$39.00
1/13/2021The Goldman Sachs GroupInitiated CoverageNeutral$35.00
12/22/2020Smith Barney CitigroupInitiated CoverageBuy$33.00
10/26/2020JPMorgan Chase & Co.Initiated CoverageOverweight$40.00
8/5/2020BarclaysReiterated RatingHold
8/4/2020Needham & Company LLCBoost TargetBuy$28.00 ➝ $38.00
5/14/2020Needham & Company LLCReiterated RatingBuy$28.00
2/25/2020BarclaysReiterated RatingHold$25.00
2/24/2020Needham & Company LLCBoost TargetBuy$26.00 ➝ $28.00
11/21/2019Needham & Company LLCReiterated RatingBuy$26.00
(Data available from 11/10/2019 forward)

News Sentiment Rating

0.43 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 8 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
4/14/2024
  • 9 very positive mentions
  • 19 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
5/14/2024
  • 3 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/13/2024
  • 3 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/13/2024
  • 11 very positive mentions
  • 18 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/12/2024
  • 5 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/11/2024
  • 8 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
10/11/2024
  • 3 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/10/2024

Current Sentiment

  • 3 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.
Sapiens International logo
Sapiens International Corporation N.V. provides software solutions for the insurance industry in North America, the United Kingdom, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides various solutions for property and casualty commercial and personal lines, life and pensions, and reinsurance fields. It offers IDITSuite, an AI powered, end-to-end insurance software; DigitalSuite, a cloud-native, future-proof digital engagement platform; IDITGo, a pre-configured, data-enriched insurance launch and accelerator platform solutions; consultancy services for property and casualty commercial lines; and Tia Enterprise solution for customer engagement. The company also provides CoreSuite, an end-to-end cloud and digital PAS for individual and group products across life, health, wealth, and pensions; CustomerConnect, a dynamic self-service and persona-based portal to engage with insureds; AgentConnect, a portal for agents and brokers to focus on sales enablement, customer retention, and increasing customer value; and ReinsuranceMaster, a reinsurance automation software that provides insurers full financial control and flexibility over their entire reinsurance process. The company was founded in 1982 and is headquartered in Holon, Israel.
Read More

Today's Range

Now: $39.45
Low: $39.26
High: $39.65

50 Day Range

MA: $36.48
Low: $34.89
High: $39.48

52 Week Range

Now: $39.45
Low: $24.39
High: $41.22

Volume

164,278 shs

Average Volume

79,245 shs

Market Capitalization

$2.20 billion

P/E Ratio

32.34

Dividend Yield

1.47%

Beta

1.25

Frequently Asked Questions

What sell-side analysts currently cover shares of Sapiens International?

The following Wall Street analysts have issued research reports on Sapiens International in the last twelve months: Barclays PLC, Needham & Company LLC, StockNews.com, and The Goldman Sachs Group, Inc..
View the latest analyst ratings for SPNS.

What is the current price target for Sapiens International?

0 Wall Street analysts have set twelve-month price targets for Sapiens International in the last year. Their average twelve-month price target is $41.67, suggesting a possible upside of 5.6%. Needham & Company LLC has the highest price target set, predicting SPNS will reach $44.00 in the next twelve months. Barclays PLC has the lowest price target set, forecasting a price of $38.00 for Sapiens International in the next year.
View the latest price targets for SPNS.

What is the current consensus analyst rating for Sapiens International?

Sapiens International currently has 1 sell rating and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in SPNS, but not buy more shares or sell existing shares.
View the latest ratings for SPNS.

What other companies compete with Sapiens International?

How do I contact Sapiens International's investor relations team?

Sapiens International's physical mailing address is Azrieli Center 26 Harukmim St., Holon L3, 5885800. The technology company's listed phone number is (723) 790-2000 and its investor relations email address is [email protected]. The official website for Sapiens International is www.sapiens.com. Learn More about contacing Sapiens International investor relations.